ABP News on MSN
Astro analysis | Does your name's spelling affect your luck? Double R in Nushrratt, Irrfan and Kirron Kher explained
The spelling of a name has often attracted attention in the entertainment industry, with several celebrities making changes ...
Morning Overview on MSN
UCSF turned immune cells into cancer killers inside the body, clearing leukemia in nearly all mice
Eighteen of 20 mice with an aggressive B-cell leukemia reached a complete response after a single injection that built cancer ...
Conclusion: ATG-207 combines CD3-mediated T cell modulation with TGFβRIII-biased TGF-β signaling to suppress pathogenic T cells while promoting regulatory T cell differentiation. These preclinical ...
A case report describes an exceptionally rare instance of wild-type transthyretin amyloidosis confined to the ...
The final results of the German CARO study show that carfilzomib-based regimens achieve high adherence, trial-consistent ...
As we commented last time, patients can be very fearful of the side effects that chemotherapy may incur. Often, these side effects may seem vague or formless, though most people are aware of nausea ...
Hemispherian AS is a clinical-stage pharmaceutical company developing first-in-class small-molecule cancer therapies. Its lead program, GLIX1, is being advanced in partnership with BioLineRx for the ...
Bristol Myers Squibb Announces ZENBEXUSTM (iberdomide) in Combination with Daratumumab and Dexamethasone (ZDd) Demonstrates ...
以色列特拉维夫与挪威奥斯陆，2026年10月8日/美通社/——BioLineRx有限公司（纳斯达克：BLRX）（特拉维夫证券交易所：BLRX），一家致力于在肿瘤学和罕见病领域开发改变生命的疗法的临床阶段生物制药公司，以及HemispherianAS公 ...
TELAVIV, Israel and OSLO, Norway, Oct. 8, 2026 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results